XML 33 R23.htm IDEA: XBRL DOCUMENT v3.23.1
Net Loss Per Common Share
6 Months Ended
Jun. 30, 2022
Earnings Per Share [Abstract]  
Net Loss Per Common Share
17.
NET LOSS PER COMMON SHARE

The computation of basic and diluted net loss per common share is based on net loss attributable to Biote stockholders divided by the basic and diluted weighted average number of shares of Class A Common Stock outstanding, each for the period subsequent to the consummation of the Business Combination. The following table sets forth the computation of net loss per common share:

 

 

Three Months Ended
June 30,

 

 

Six Months Ended
June 30,

 

 

 

2022

 

 

2022

 

Net loss per common share

 

 

 

 

 

 

Numerator:

 

 

 

 

 

 

Net loss attributable to biote Corp. stockholders (basic and diluted)

 

$

(2,606

)

 

$

(2,606

)

Denominator:

 

 

 

 

 

 

Weighted average shares outstanding (basic and diluted)

 

 

7,574,271

 

 

 

7,574,271

 

Net loss per common share

 

 

 

 

 

 

Basic

 

$

(0.34

)

 

$

(0.34

)

Diluted

 

$

(0.34

)

 

$

(0.34

)

On the Closing Date, the Company completed the Business Combination which materially impacted the number of shares outstanding, and the Combined Company was organized in an Up-C structure. Net loss per common share information for the three and six months ended June 30, 2022 has been presented on a prospective basis and reflects only the net loss attributable to holders of Biote’s Class A Common Stock, as well as both basic and diluted weighted average Class A Common Stock outstanding, for the period from the Closing Date through June 30, 2022. Net income (loss) per common share information prior to the Closing Date is not presented since the ownership structure of Holdings is not a common unit of ownership of the Company, and the resulting values would not be meaningful to the users of the condensed consolidated financial statements. Net loss per common share is not separately presented for Class V Voting Stock since it has no economic rights to the income or loss of the Company. Class V Voting Stock is considered in the calculation of dilutive net loss per common share on an if-converted basis as these shares, together with the related Biote Units, have Exchange Rights into Class A Common Stock that could result in additional Class A Common Stock being issued. All other potentially dilutive securities are determined based on the treasury stock method. See Note 1 for more information regarding the Business Combination.

The Company excluded the following potential shares, presented based on amounts outstanding at each period end, from the computation of diluted weighted average shares outstanding for the periods indicated because including them would have had an antidilutive effect:

 

 

Three Months Ended
June 30,

 

 

Six Months Ended
June 30,

 

 

 

2022

 

 

2022

 

RSUs

 

 

3,887,750

 

 

 

3,887,750

 

Class V Voting Stock

 

 

48,565,824

 

 

 

48,565,824

 

Public Warrants

 

 

7,937,500

 

 

 

7,937,500

 

Private Placement Warrants

 

 

5,566,666

 

 

 

5,566,666

 

Earnout Voting Shares

 

 

10,000,000

 

 

 

10,000,000

 

Sponsor Earnout Shares

 

 

1,587,500

 

 

 

1,587,500

 

 

 

 

77,545,240

 

 

 

77,545,240